Medicare Quality Cancer Care Demonstration Act (original) (raw)
The United States Medicare Quality Cancer Care Demonstration Act of 2009 (H.R. 2872), is a landmark national initiative intended to enhance the quality of cancer care, focused on seniors who covered by Medicare. Approximately 45% of cancer patients are Medicare beneficiaries, while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives, Steve Israel (D-NY) and Mary Jo Kilroy (D-OH). The bill includes the following elements:
| Property | Value |
|---|---|
| dbo:abstract | The United States Medicare Quality Cancer Care Demonstration Act of 2009 (H.R. 2872), is a landmark national initiative intended to enhance the quality of cancer care, focused on seniors who covered by Medicare. Approximately 45% of cancer patients are Medicare beneficiaries, while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives, Steve Israel (D-NY) and Mary Jo Kilroy (D-OH). The Quality Cancer Care Demonstration (QCCD) project was developed by a community of oncologists, with inputs from policy experts, to be a national Medicare demonstration project focused on two key aspects of cancer care: treatment planning and end-of-life care. Treatment planning involves all essential components of establishing the cancer care plan and monitoring its effectiveness. End-of-life care involves all essential components of patient-centric cancer care, relating to individuals facing end-of-life planning and decision-making. By the Medicare payment system, H.R. 2872 calls for national reporting of key metrics of evidence-based care, and also refines those metrics; develops new Medicare performance-based reimbursement system that is patient-centric and quality driven, while aligning better with cost control. The bill includes the following elements: * Establish a national Medicare demonstration project implemented by the Centers for Medicare & Medicaid Services (CMS) and is open to all oncology practices. * Address current shortcomings in treatment planning and end-of-life care by improving metrics and aligning incentives relating to the care. * Quality reporting measures by oncologists through the Medicare reimbursement system, concerning their treatment plans and end-of-life care. It would also include refinement and improvement of these plans. * Allocate $300 million per year in Medicare funding to revise the Medicare payment system. Those payments would be based on quality and cost-efficiency. * Incorporate the key elements under discussion in the healthcare reform debate — quality care delivery, evidence-based medicine, care coordination, patient-centric, cost control, health information technology, and pay-for-performance — in producing an evolved payment system. * Evaluation of QCCD to determine the participation of oncologists and cost-effectiveness of the plan. * Conducting of a demonstration project over a period of not less than two years to allow for improvement in reporting, metrics, and analysis. * A substantive project that can be implemented within 6 months by CMS and will be available to all oncologists nationwide. * Could serve as a model for other areas of specific care relating to terminal illness for Medicare beneficiaries. (en) |
| dbo:wikiPageID | 24542827 (xsd:integer) |
| dbo:wikiPageLength | 3568 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1121366296 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:End-of-life_care dbr:Medicare_(United_States) dbr:Steve_Israel dbr:Pay_for_performance_(healthcare) dbr:Centers_for_Medicare_and_Medicaid_Services dbr:Health_information_technology dbr:Healthcare_reform_debate_in_the_United_States dbr:Landmark dbc:Medicare_and_Medicaid_(United_States) dbr:Cost-effectiveness_analysis dbr:Terminal_illness dbr:Artur_Davis dbc:Healthcare_reform_legislation_in_the_United_States dbr:Mary_Jo_Kilroy dbr:Old_age dbr:Evidence-based_medicine dbr:National_Quality_Cancer_Care_Demonstration_Project_Act_of_2009 dbr:Cancer_care dbr:Treatment_planning |
| dbp:wikiPageUsesTemplate | dbt:Advert dbt:Multiple_issues dbt:Refimprove dbt:Reflist dbt:USBill dbt:Update |
| dct:subject | dbc:Medicare_and_Medicaid_(United_States) dbc:Healthcare_reform_legislation_in_the_United_States |
| gold:hypernym | dbr:Landmark |
| rdf:type | dbo:Building |
| rdfs:comment | The United States Medicare Quality Cancer Care Demonstration Act of 2009 (H.R. 2872), is a landmark national initiative intended to enhance the quality of cancer care, focused on seniors who covered by Medicare. Approximately 45% of cancer patients are Medicare beneficiaries, while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives, Steve Israel (D-NY) and Mary Jo Kilroy (D-OH). The bill includes the following elements: (en) |
| rdfs:label | Medicare Quality Cancer Care Demonstration Act (en) |
| owl:sameAs | freebase:Medicare Quality Cancer Care Demonstration Act wikidata:Medicare Quality Cancer Care Demonstration Act https://global.dbpedia.org/id/4s4ua |
| prov:wasDerivedFrom | wikipedia-en:Medicare_Quality_Cancer_Care_Demonstration_Act?oldid=1121366296&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:Medicare_Quality_Cancer_Care_Demonstration_Act |
| is dbo:wikiPageRedirects of | dbr:H.R._2872_Quality_Cancer_Care_Demonstration_Project dbr:Quality_Cancer_Care_Demonstration_Project |
| is dbo:wikiPageWikiLink of | dbr:Medicare_(United_States) dbr:H.R._2872_Quality_Cancer_Care_Demonstration_Project dbr:National_Quality_Cancer_Care_Demonstration_Project_Act_of_2009 dbr:Quality_Cancer_Care_Demonstration_Project |
| is foaf:primaryTopic of | wikipedia-en:Medicare_Quality_Cancer_Care_Demonstration_Act |